Skip to main content

Syndromic Wilms’ Tumor

  • Chapter
  • First Online:
Wilms’ Tumor
  • 361 Accesses

Abstract

Wilms’ tumor (WT) is known to be associated with various genetic syndromes and several distinct clinical conditions. This chapter will highlight the epidemiology, incidence, and burden of disease of syndromic WT and their association with various genetic and clinical abnormalities. The learning points will focus on identifying these at-risk patients, with guidelines for screening and follow-up, tailored medical and surgical therapy in these patients, and long-term effects and considerations of transition care to adulthood in this group.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hentrich MU, Meister P, Brack NG, Lutz LL, Hartenstein RC. Adult Wilms’ tumor. Report of two cases and review of the literature. Cancer. 1995;75:545–51.

    Article  CAS  Google Scholar 

  2. Ritchey ML, Shamberger RC, Hamilton T, Haase G, Argani P, Peterson S. Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group. J Urol. 2005;174:1519–21. https://doi.org/10.1097/01.ju.0000179536.97629.c5.

    Article  PubMed  Google Scholar 

  3. Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P. Familial Wilms’ tumor: a descriptive study. Med Pediatr Oncol. 1996;27:398–403. https://doi.org/10.1002/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H.

    Article  CAS  PubMed  Google Scholar 

  4. Dome JS, Huff V. Wilms tumor predisposition. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle: University of Washington; 2003.

    Google Scholar 

  5. Merks JH, Caron HN, Hennekam RC. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A. 2005;134:132–43. https://doi.org/10.1002/ajmg.a.30603.

    Article  Google Scholar 

  6. Tolbert VP, Coggins GE, Maris JM. Genetic susceptibility to neuroblastoma. Curr Opin Genet Dev. 2017;42:81–90. https://doi.org/10.1016/j.gde.2017.03.008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Weksberg R, Brzezinski J. Identifying new Wilms’ tumour predisposition genes. Lancet Child Adolesc Health. 2019;3:285–7. https://doi.org/10.1016/S2352-4642(19)30064-1.

    Article  PubMed  Google Scholar 

  8. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumor. J Med Genet. 2006;43:705–15. https://doi.org/10.1136/jmg.2006.041723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Royer-Pokora B, Beier M, Henzler M, Alam R, Schumarjer V, Weirich A, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet. 2004;127:249–57. https://doi.org/10.1002/ajmg.a.30015.

    Article  Google Scholar 

  10. Muto R, Yamamori S, Ohashi H, Osawa M. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients. Am J Med Genet. 2002;108:285–9. https://doi.org/10.1002/ajmg.10094.

    Article  PubMed  Google Scholar 

  11. Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet. 1998;79:268–73.

    Article  CAS  Google Scholar 

  12. Breslow NE, Norris R, Norkool PA, Kang T, Beckwith JB, Perlman EJ, et al. Characteristics and outcomes of children with the Wilms tumor-aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003;21:4579–85. https://doi.org/10.1200/JCO.2003.06.096.

    Article  PubMed  Google Scholar 

  13. Ferreira M, Almeida Júnior I, Kuratani D, Rosa R, Gonzales J, Telles L, et al. WAGRO syndrome: a rare genetic condition associated with aniridia and additional ophthalmologic abnormalities. Arq Bras Oftalmol. 2019;82:336–8. https://doi.org/10.5935/0004-2749.20190065.

    Article  PubMed  Google Scholar 

  14. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005;116:984–8. https://doi.org/10.1542/peds.2004-0467.

    Article  PubMed  Google Scholar 

  15. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, et al. Brain- derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359:918–27. https://doi.org/10.1056/NEJMoa0801119.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Denys P, Malvaux P, Van den BH, Tanghe W, Proesmans W. Association of an anatomopathological syndrome of male pseudohermaphroditism, Wilms’ tumor, parenchymatous nephropathy and XX/XY mosaicism. Arch Fr Pediatr. 1967;24:729–39.

    CAS  PubMed  Google Scholar 

  17. Drash A, Sherman F, Hartmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J Pediatr. 1970;76:585–93. https://doi.org/10.1016/s0022-3476(70)80409-7.

    Article  CAS  PubMed  Google Scholar 

  18. Mueller RF. The Denys-Drash syndrome. J Med Genet. 1994;31:471–7. https://doi.org/10.1136/jmg.31.6.471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Frasier S, Bashore R, Mosier H. Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins. J Pediatr. 1964;64:740–5. https://doi.org/10.1016/s0022-3476(64)80622-3.

    Article  CAS  PubMed  Google Scholar 

  20. Finken MJ, Hendriks YM, van der Voorn JP, Veening MA, Lombardi MP, Rotteveel J. WT1 deletion leading to severe 46XY gonadal dysgenesis, Wilms tumor and gonadoblastoma: case report. Horm Res Paediatr. 2015;83:211–6. https://doi.org/10.1159/000368964.

    Article  CAS  PubMed  Google Scholar 

  21. Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clin Endocrinol. 2000;52:519–24. https://doi.org/10.1046/j.1365-2265.2000.00980.x.

    Article  CAS  Google Scholar 

  22. Thorburn MJ, Wright ES, Miller CG, Smith-Read EH. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child. 1970;119:316–21. https://doi.org/10.1001/archpedi.1970.02100050318006.

    Article  CAS  PubMed  Google Scholar 

  23. Choyke PL, Siegel MJ, Sotelo-Avila C, De Baun MR. Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome. Am J Roentgenol. 1998;171:733–7. https://doi.org/10.2214/ajr.171.3.9725306.

    Article  CAS  Google Scholar 

  24. Bliek J, Maas S, Alders M, Merks JH, Mannens M. Epigenotype, phenotype, and tumors in patients with isolated hemihyperplasia. J Pediatr. 2008;153:95–100. https://doi.org/10.1016/j.jpeds.2007.12.022.

    Article  CAS  PubMed  Google Scholar 

  25. Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010;18:8–14. https://doi.org/10.1038/ejhg.2009.106.

    Article  PubMed  Google Scholar 

  26. Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M. Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998;79:274–8.

    Article  CAS  Google Scholar 

  27. Mariani S, Iughetti L, Bertorelli R, Coviello D, Pellegrini M, Forabosco A, et al. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature. J Pediatr Endocrinol Metab. 2003;16:225–32. https://doi.org/10.1515/jpem.2003.16.2.225.

    Article  CAS  PubMed  Google Scholar 

  28. Song HH, Shi W, Xiang YY, Filmus J. The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem. 2005;280:2116–25. https://doi.org/10.1074/jbc.M410090200.

    Article  CAS  PubMed  Google Scholar 

  29. Perlman M, Levin M, Wittels B. Syndrome of fetal gigantism, renal hamartomas, and nephroblastomatosis with Wilms’ tumor. Cancer. 1975;35:1212–7.

    Article  CAS  Google Scholar 

  30. Henneveld HT, van Lingen RA, Hamel BC, Stolte-Dijkstra I, van Essen AJ. Perlman syndrome: four additional cases and review. Am J Med Genet. 1999;86:439–46.

    Article  CAS  Google Scholar 

  31. Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet. 2005;137:53–71. https://doi.org/10.1002/ajmg.c.30064.

    Article  Google Scholar 

  32. Reid S, Renwick A, Seal S, Baskcomb L, Barfoot R, Jayatilake H, et al. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet. 2005;42:147–51. https://doi.org/10.1136/jmg.2004.022673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rahman N, Abidi F, Ford D, Arbour L, Rapley E, Tonin P, et al. Confirmation of FWT1 as a Wilms’ tumour susceptibility gene and phenotypic characteristics of Wilms’ tumour attributable to FWT1. Hum Genet. 1998;103:547–56. https://doi.org/10.1007/pl00008708.

    Article  CAS  PubMed  Google Scholar 

  34. Cairney AE, Andrews M, Greenberg M, Smith D, Weksberg R. Wilms tumor in three patients with Bloom syndrome. J Pediatr. 1987;111:414–6. https://doi.org/10.1016/s0022-3476(87)80469-9.

    Article  CAS  PubMed  Google Scholar 

  35. Llis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, et al. The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell. 1995;83:655–66. https://doi.org/10.1016/0092-8674(95)90105-1.

    Article  Google Scholar 

  36. Kajii T, Kawai T, Takumi T, Misu H, Mabuchi O, Takahashi Y, et al. Mosaic variegated aneuploidy with multiple congenital abnormalities: homozygosity for total premature chromatid separation trait. Am J Med Genet. 1998;78:245–9. https://doi.org/10.1002/(sici)1096-8628(19980707)78:3<245::aid-ajmg7>3.0.co;2-o.

    Article  CAS  PubMed  Google Scholar 

  37. Meyer S, Fergusson WD, Oostra AB, Medhurst AL, Waisfisz Q, deWinter JP, et al. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations. Genes Chromosomes Cancer. 2005;42:404–15. https://doi.org/10.1002/gcc.20153.

    Article  CAS  PubMed  Google Scholar 

  38. Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, et al. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol. 2005;25:5052–60. https://doi.org/10.1128/MCB.25.12.5052-5060.2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002;19:607–14. https://doi.org/10.1002/humu.10081.

    Article  CAS  PubMed  Google Scholar 

  40. Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet. 2004;41:92–8. https://doi.org/10.1136/jmg.2003.014118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Fabia J, Drolette M. Malformations and leukemia in children with Down’s syndrome. Pediatrics. 1970;45:60–70.

    Article  CAS  Google Scholar 

  42. Narchi H. Risk of Wilms’ tumour with multicystic kidney disease: a systematic review. Arch Dis Child. 2005;90:147–9. https://doi.org/10.1136/adc.2004.051243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Stiller CA, Lennox EL, Wilson LM. Incidence of cardiac septal defects in children with Wilms’ tumour and other malignant diseases. Carcinogenesis. 1987;8:129–32. https://doi.org/10.1093/carcin/8.1.129.

    Article  CAS  PubMed  Google Scholar 

  44. Merks JH, Smets AM, Van Rijn RR, Kobes J, Caron HN, Maas M, et al. Prevalence of rib anomalies in normal Caucasian children and childhood cancer patients. Eur J Med Genet. 2005;48:113–29. https://doi.org/10.1016/j.ejmg.2005.01.029.

    Article  PubMed  Google Scholar 

  45. Scott RH, Anne Murray A, Baskcomb L, Turnbull C, Loveday C, Al-Saadi R, et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget. 2012;3:327–35. https://doi.org/10.18632/oncotarget.468.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lange J, Peterson SM, Takashima JR, Grigoriev Y, Ritchey M, et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol. 2011;186:378. https://doi.org/10.1016/j.juro.2011.03.110.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Auber F, Jeanpierre C, Denamur E, Jaubert F, Schleiermacher M, Patte C, et al. Management of Wilms tumors in drash and frasier syndromes. Pediatr Blood Cancer. 2009;52:55–9. https://doi.org/10.1002/pbc.21759.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Peters, N.J., Samujh, R. (2022). Syndromic Wilms’ Tumor. In: Sarin, Y.K. (eds) Wilms’ Tumor. Springer, Singapore. https://doi.org/10.1007/978-981-19-3428-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-3428-5_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-3427-8

  • Online ISBN: 978-981-19-3428-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics